Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

[Prognostic value of anti-TSH receptor antibodies in Basedow's disease treated with carbimazole].

Duprey J, Izembart M, Vallée G, Goupil M.

Ann Med Interne (Paris). 1986;137(7):555-8. French.

PMID:
3813296
2.

Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.

Bojarska-Szmygin A, Janicki K, Pietura R, Janicka L.

Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):248-53.

PMID:
15314994
3.

[The effect of thyrostatic treatment on circulating thyrotropin-receptor antibodies in Basedow's disease].

Lozanov B, Kirilov G, Ivanova R, Khubaveshki S.

Vutr Boles. 1990;29(3):79-84. Bulgarian.

PMID:
1704667
4.
5.

[Recurrence of Graves-Basedow disease: the influence of treatment schedule].

Goñi Iriarte MJ, Forga Llenas L, Iriarte Beroiz A, Apiñániz EA, Rodríguez Erdozain R, Menéndez Torre E.

Med Clin (Barc). 1995 Jan 14;104(1):11-4. Spanish.

PMID:
7877347
6.

[Carbimazole therapy in Basedow's disease: therapy results in individual dosage adjustment].

Trabucco P, Engler H, Ryff-de Lèche A, Althaus B, Staub JJ.

Schweiz Med Wochenschr. 1989 Dec 30;119(52):1894-8. German.

PMID:
2609144
7.
8.

[Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases].

Bojarska-Szmygin A, Ciechanek R, Jezierska B, Zaorska-Rajca J.

Pol Merkur Lekarski. 2002 Sep;13(75):196-9. Polish.

PMID:
12474569
10.

[Occurrence of TSH receptor antibodies and thyroid microsomal antibodies in Graves-Basedow disease].

Paunković N, Paunković D.

Med Pregl. 1995;48(1-2):10-4. Croatian.

PMID:
8657049
12.

Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.

Schott M, Morgenthaler NG, Fritzen R, Feldkamp J, Willenberg HS, Scherbaum WA, Seissler J.

Horm Metab Res. 2004 Feb;36(2):92-6.

PMID:
15002058
14.

Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.

Harper L, Chin L, Daykin J, Allahabadia A, Heward J, Gough SC, Savage CO, Franklyn JA.

Clin Endocrinol (Oxf). 2004 Jun;60(6):671-5.

PMID:
15163328
15.

TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.

Wallaschofski H, Kuwert T, Lohmann T.

Exp Clin Endocrinol Diabetes. 2004 Apr;112(4):171-4. Review.

PMID:
15127319
16.

[TSH anti-receptor antibodies in Graves' disease].

Sérgio MR, Godinho C, Guerra L, Agapito A, Fonseca F, Costa C.

Acta Med Port. 1996 Jul-Sep;9(7-9):229-31. Portuguese.

17.

[Improvement of the prognosis of Basedow's disease by using high doses of carbimazole].

Duprey J, Louis MF, Ducornet B, Lifchitz E, Mossé A, Sultan M, Izembart M.

Presse Med. 1988 Jun 4;17(22):1124-7. French.

PMID:
2969532
18.

[Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Graves' disease].

Rink T, Holle LH, Schroth HJ, Garth H.

Nuklearmedizin. 1998 May;37(3):90-4. German.

PMID:
9604228
19.

TSH-receptor antibody (TSH-R Ab) variations in patients undergoing subtotal thyroidectomy for Graves' disease: a prospective study.

Rubello D, Casara D, Pelizzo MR, Girelli ME, Piotto A, Piccolo M, Busnardo B.

J Nucl Biol Med. 1993 Jun;37(2):73-6.

PMID:
8373836
20.

Occurrence of antibodies to insulin in patients with autoimmune thyroid disease.

Ng WY, Thai AC, Lui KF, Cheah JS.

Ann Acad Med Singapore. 1993 Jul;22(4):544-8.

PMID:
8257055

Supplemental Content

Support Center